Introduction {#S1}
============

Motor abnormalities constitute an integral part of schizophrenia. Aberrant motor function was included as one of eight dimensions of psychopathology in schizophrenia spectrum disorders in the current version of the diagnostic and statistical manual (DSM-5) (2014). Aberrant motor function was frequently observed in both medicated and unmedicated patients ([@B1], [@B2]). In addition, aberrant motor function often wax and wane during follow-up ([@B3], [@B4]). At least one motor sign was present in about 66% of patients in first-episodes ([@B5]), in 59% of patients on admission ([@B6]), and 80% of chronic patients ([@B1], [@B7]). Alterations incorporate various domains of motor function. Domains include for instance neurological soft signs (NSS) (i.e., motor coordination, sequencing, and sensory integration) ([@B8]), dyskinesia (abnormal involuntary movements typically manifest as involuntary continuous orofacial movements and dyskinetic movements of the extremities or trunk) ([@B9], [@B10]), parkinsonism (bradykinesia, rigor, tremor) ([@B10]), catatonic symptoms (pure motor signs, disturbance of volition, inability to suppress motor reactions and vegetative instability) \[for review, see e.g., Ref. ([@B1], [@B11], [@B12])\], deficits in fine motor function \[i.e., the coin rotation task, the Moberg pick-up test ([@B13], [@B14]), finger sequencing and the pegboard test ([@B15])\], and psychomotor slowing ([@B16]). In sum, schizophrenia patients show generalized aberrant motor function.

Another important line of evidence stems from first-degree relatives of psychosis patients. Aberrant motor function in these subjects may help find markers who are associated with the genetic risk for schizophrenia. However, a comprehensive assessment of a wide range of domains of motor function in first-degree relatives is missing. Thus, it remains unknown, which particular motor domain may serve as a potential genetic risk marker.

In detail, previous reports suggest delayed motor development as a genetic risk marker. For instance, it was hypothesized that NSS arise due to neurodevelopmental delay in motor function in young subjects at risk and first-degree relatives. NSS are subtle neurological deficits ([@B17], [@B18]) which are seen in children and normally vanish during the motor development in late childhood. An association of NSS with the genetic risk for schizophrenia has consistently been reported ([@B19]), possibly even predictive for the transition to psychosis ([@B20]). Nearly, all studies investigating NSS in unaffected first-degree relatives detected higher prevalence of NSS in relatives compared to healthy controls. This has been substantiated by recent meta-analyses ([@B8], [@B21]).

Whether dyskinesia and Parkinsonism are associated with the genetic risk to develop schizophrenia is less clear than for NSS ([@B22], [@B23]). Even though, most reports show increased incidence of dyskinesia and Parkinsonism in schizophrenia relatives, which has been confirmed in a recent meta-analysis ([@B24]). Yet, for instance, Tarbox and Pogue-Geile ([@B25]) detected no increased prevalence of dyskinesia in relatives. As for dyskinesia, from the available data, it is difficult to state whether Parkinsonism may serve as a genetic risk marker for psychosis. Some reports showed increased incidence in unaffected relatives ([@B24], [@B26]) with some inconsistency ([@B27]).

One further important domain of motor function is fine motor function (i.e., manual skills and dexterity) ([@B28]). Schizophrenia patients suffer from defective complex fine motor function, as measured by the Line Copying Task or the coin rotation test ([@B14]) as well as simple fine motor function as measured by the finger tapping (FT) task \[e.g., Ref. ([@B14], [@B29], [@B30])\]. Fine motor impairments are already present at the beginning of the disorder in the first episode. These deficits seem to be relatively stable over time ([@B31]). Moreover, defective fine motor function may impact activities of daily living and may be associated with poor functional outcome as has been shown in other conditions (i.e., Parkinson's disease) ([@B32], [@B33]) In general, a loss of complex fine motor skills may not solely be explained by elemental motor deficits such as motor slowing (bradykinesia) but might also reflect disturbances of more complex motor function such as selectively control and coordination of upper limb and specifically finger movements ([@B34], [@B35]). Whether fine motor function is linked to the genetic risk for psychosis is unclear. One single report detected aberrant simple fine motor function (measured with FT) in unaffected first-degree relatives of psychotic patients ([@B36]). Likewise another study found reduced complex fine motor function (i.e., tested with inserting long and short pins into holes in a platform) in subjects at risk ([@B37]). However, complex fine motor function of the fingers (i.e., finger dexterity measured with the coin rotation task) has not been tested.

In sum, there is considerable and consistent evidence for the association of NSS and the risk to develop schizophrenia. A moderate number of studies suggest an association of dyskinesia and Parkinsonism with schizophrenia risk with some inconsistency. In addition, only few studies addressed the association of complex fine motor function and psychosis risk. Moreover, former investigations focused only on one motor domain. Thus, which domain of motor function is associated with a genetic psychosis risk and how they are interlinked is still unknown.

Therefore, the aim of our study was to compare for the first time a comprehensive motor battery, including motor function in four domains (NSS, dyskinesia, Parkinsonism and fine motor function) in three well-characterized groups (patients, unaffected first-degree relatives and healthy controls). In line with the literature, we expected generalized aberrant motor function in schizophrenia patients. Further, we expected aberrant motor function in some but not all motor domains in unaffected first-degree relatives. In detail, we hypothesized increased incidence of NSS and aberrant fine motor function in unaffected relatives, but no increased incidence of dyskinesia and Parkinsonism.

Materials and Methods {#S2}
=====================

Subjects {#S2-1}
--------

This study included 41 patients with schizophrenia, 34 first-degree relatives (parents, siblings, or children) and 29 healthy controls matched for gender, age, and education. All participants were right-handed as determined by the Edinburgh handedness inventory ([@B38]) and were native German speakers. This study was carried out in accordance with the recommendations of the local Ethics Committee (Kantonale Ethikkommission: KEK Bern) with written informed consent from all subjects.

Patients were in- and outpatients recruited at the University Hospital of Psychiatry, Bern and diagnosed according to DSM-5. Relatives were contacted via patients with schizophrenia and the Association of Schizophrenia Patients' Relatives, Bern. Inclusion criterion for relatives was a history or presence of any physician-diagnosed schizophrenia spectrum disorder in at least one first-degree relative. Controls were volunteers recruited from the hospital staff and the community without first-degree relatives with schizophrenia spectrum disorders.

General exclusion criteria for all participants were substance abuse or dependence other than nicotine and past or current medical or neurological condition associated with impaired movement (i.e., dystonia, idiopathic Parkinsonism, or stroke).

All Participants were interviewed by trained psychiatrists using the Mini-International Neuropsychiatric Interview ([@B39]) (adapted for DSM-5). In addition, we assessed frontal lobe function using the Frontal Assessment Battery (FAB) ([@B40]), verbal working memory with the digit span backwards (DSB) task \[subtest from the Wechsler Memory Scale (WMS-III)\] ([@B41]) as well as nonverbal intelligence using the short Test of nonverbal Intelligence (TONI) ([@B42]).

Motor Behavior {#S2-2}
--------------

We assessed four different domains of motor function using a comprehensive battery including the neurological evaluation scale (NES) ([@B18]) to assess NSS, the Abnormal Involuntary Movement Scale (AIMS) ([@B43]) for dyskinesia, and the Unified Parkinson's Disease Rating Scale (UPDRS) ([@B44]) for Parkinsonism. In addition, participants performed a complex and a simple fine-motor tasks. During the complex fine-motor task, the coin rotation task (CR), a coin (Swiss 50-Rappen coin, corresponding exactly in size to a US-Nickel) is rotated between thumb and fingers one and two (index and middle finger) in 10 s as fast as possible. A correction for drops is used \[the adjusted score is the number of rotations in 10 s minus (0.1 × rotations × drops)\] ([@B34], [@B45], [@B46]). After a short training period, each participant performed three trials of 10 s with each hand. Performance was videotaped and analyzed in slow motion by a blinded rater. The last half-turn was included when at least half of the movement was completed. Finally, participants performed a simple fine motor task, the FT task. They were instructed to tap their index finger and thumb with the maximum amplitude as fast as possible. This task was also performed for three times during 10 s with each hand. Again, performance was video recorded and analyzed by a blinded rater.

Statistical Analysis {#S2-3}
--------------------

Statistical tests were performed using SPSS 24.0 (SPSS Inc., Chicago, IL, USA). Univariate analysis of variance, chi-square tests (χ^2^), and general linear models were used to test the continuous and categorical clinical variables between groups (relatives, patients and controls). Our main interest was to assess whether patients and relatives had more severe motor abnormalities than controls. Therefore, we first compared ratings of motor scales between groups using univariate analyses of variance. *Post hoc* tests included Sidak correction for multiple comparisons. Next, we calculated two separate repeated measures ANOVAs of performance in the two fine motor tasks with side (left and right hand) as within-subject factor. To test the association of aberrant motor function as well as working memory and frontal lobe function, we correlated scores of each scale and task for each group (patients, relatives and controls) separately, applying within-group bivariate correlations. Significance level was set at *p* \< 0.05 two-tailed.

Results {#S3}
=======

Clinical and demographic data are given in Table [1](#T1){ref-type="table"}. Groups did not differ in age, gender, and education. However, groups differed regarding nonverbal intelligence and working memory, for which patients had inferior performance compared to relatives or controls. In addition, patients had poorer frontal lobe function at trend level (*p* = 0.081) compared to healthy controls (see Table [2](#T2){ref-type="table"}).

###### 

Demographic data and clinical status of the groups.

                Controls (C); *N* 29   Relatives (R); *N* 34   Patients (P); *N* 43   df   *F*/χ^2^   *p*-Value
  ------------- ---------------------- ----------------------- ---------------------- ---- ---------- -----------
  Age           40.86 ± 14.38          42.74 ± 15.73           37.98 ± 11.37          2    1.18       0.312
  Gender        55.2% (f)              64.7% (f)               62.8% (f)              2    0.67       0.768
  EDU           13.79 ± 2.32           14.18 ± 3.02            13.52 ± 3.12           2    0.49       0.617
  DOI (years)   --                     --                      12.92 ± 12.48                          
  PANSS tot     --                     --                      71.14 ± 16                             
  PANSS pos     --                     --                      17.98 ± 6.28                           
  PANSS neg     --                     --                      18.14 ± 5.15                           

*N, number; f, female; EDU, education (years); DOI, duration of illness; PANSS, Positive and Negative Syndrome Scale; tot, total; pos, positive; neg, negative*.

###### 

Nonverbal intelligence, frontal lobe and working memory function of the groups.

  -------------------------------------------------------------------------------------------------------------------------------------------
         Controls (C); *N* 29   Relatives (R); *N* 34   Patients (P); *N* 43   df   *F*/χ^2^   *p*-Value     *Post hoc*\
                                                                                                             Sidak corrected
  ------ ---------------------- ----------------------- ---------------------- ---- ---------- ------------- --------------------------------
  TONI   109.24 ± 10.50         108.15 ± 8.43           97.68 ± 11.40          2    14.28      **\<0.001**   **P \< C (***p*** \< 0.001)**\
                                                                                                             **P \< R (***p*** \< 0.001)**

  FAB    17.17 ± 0.97           16.85 ± 1.54            16.10 ± 2.72           2    2.78       0.067         P \< C (*p* \< 0.081)

  DSB    5.31 ± 0.71            5.26 ± 0.79             4.42 ± 1.05            2    9.45       **\<0.001**   **P \< C (***p*** = 0.001)**\
                                                                                                             **P \< R (***p*** = 0.001)**
  -------------------------------------------------------------------------------------------------------------------------------------------

*N, number; TONI, test of nonverbal intelligence (index scores); FAB, frontal assessment battery; DSB, digit span backwards*.

*Note: significant group differences are highlighted in bold*.

Motor Function {#S3-1}
--------------

Groups differed in incidence of aberrant motor function in the applied motor scales (see Table [3](#T3){ref-type="table"} and Figure [1](#F1){ref-type="fig"}). In detail, patients and relatives had higher NSS ratings than healthy controls, indicating more pathological signs. Next, we explored group differences in NSS subdomains (NES subscales). Again, groups differed in all measured motor functions (sensory motor function, motor coordination, motor sequencing, and others). In detail, performance of patients was worse in all subscales compared to healthy controls. Relatives demonstrated inferior performance in "motor sequencing" and "others," as well as a trend of inferiority in "sensory integration" (*p* = 0.067) compared to healthy controls. For dyskinesia and Parkinsonism differences became evident between patients and healthy controls, but not between relatives and controls.

###### 

Group differences of neurological soft sign, dyskinesia, and Parkinsonism in patients, relatives, and controls.

  ----------------------------------------------------------------------------------------------------------------------------------------------------
                           Controls (C); *N* 29   Relatives (R); *N* 34   Patients (P); *N* 43   *F*     *p*-Value     *Post hoc*\
                                                                                                                       Sidak corrected
  ------------------------ ---------------------- ----------------------- ---------------------- ------- ------------- -------------------------------
  NES total                3.90 ± 3.59            11.65 ± 8.18            13.74 ± 11.75          10.83   **\<0.001**   **R \> C (***p*** = 0.003)**\
                                                                                                                       **P \> C (***p*** \< 0.001)**

  NES\                     1.14 ± 1.19            2.94 ± 2.15             3.58 ± 5.12            4.23    **0.017**     **P \> C (***p*** = 0.015)**
  Sensory integration                                                                                                  

  NES\                     0.55 ± 0.78            1.79 ± 1.82             2.60 ± 2.84            8.09    **0.001**     **P \> C (***p*** \< 0.001)**
  Motor coordination                                                                                                   

  NES\                     1.03 ± 1.96            3.21 ± 2.72             2.60 ± 2.96            6.39    **0.002**     **R \> C (***p*** = 0.005)**\
  Sequencing                                                                                                           **P \> C (***p*** = 0.008)**

  NES\                     1.14 ± 1.43            3.71 ± 3.44             4.88 ± 4.73            9.12    **\<0.001**   **R \> C (***p*** = 0.020)**\
  Others                                                                                                               **P \> C (***p*** \< 0.001)**

  AIMS total               0.14 ± 0.52            1.15 ± 2.36             1.91 ± 2.7             5.62    **0.005**     **P \> C (***p*** = 0.003)**

  AIMS\                    0.04 ± 0.19            0.27 ± 0.75             0.26 ± 0.74            1.3     0.277         
  Facial expression                                                                                                    

  AIMS\                    0.10 ± 0.41            0.32 ± 0.73             0.23 ± 0.43            1.27    0.285         
  Lips and perioral area                                                                                               

  AIMS\                    0.0 ± 0.0              0.09 ± 0.38             0.11 ± 0.40            1.03    0.363         
  Jaw                                                                                                                  

  AIMS\                    0.0 ± 0.0              0.15 ± 0.58             0\. 17 ± 0.51          1.31    0.276         
  Tongue                                                                                                               

  AIMS\                    0.0 ± 0.0              0.15 ± 0.50             0.37 ± 0.77            3.77    **0.027**     **P \> C (***p*** = 0.024)**
  Upper extremity                                                                                                      

  AIMS\                    0.0 ± 0.0              0.0 ± 0.0               0.31 ± 0.68            6.79    **0.002**     **P \> C (***p*** = 0.008)**\
  Lower extremity                                                                                                      **P \> R (***p*** = 0.005)**

  AIMS\                    0.0 ± 0.0              0.12 ± 0.48             0.143 ± 0.43           1.23    0.296         
  Neck/shoulders/hips                                                                                                  

  UPDRS III                0.10 ± 0.56            2.50 ± 3.93             7.21 ± 7.46            17.19   **\<0.001**   **P \> R (***p*** = 0.001)**\
                                                                                                                       **P \> C (***p*** \< 0.001)**
  ----------------------------------------------------------------------------------------------------------------------------------------------------

*AIMS, Abnormal Involuntary Movement Scale; NES, Neurological Evaluation Scale; UPDRS III, Unified Parkinson's Disease Rating Sale motor part III*.

*Note: significant group differences are highlighted in bold*.

![Group differences of neurological soft sign, dyskinesia, and Parkinsonism in patients, relatives, and controls. Error bars indicate SE. NES, Neurological Evaluation Scale; sub., subscale; sen., sensory motor function; mot., motor coordination; seq., motor sequencing; AIMS, Abnormal Involuntary Movement Scale; UPDRS III, Unified Parkinson's Disease Rating Sale motor part III.](fpsyt-09-00129-g001){#F1}

In addition, we tested complex (CR) and simple fine motor function (FT) (Table [4](#T4){ref-type="table"}; Figure [2](#F2){ref-type="fig"}) exploring effects of side (left or right hand), group and group\*side interactions. For CR, we found an effect of side in favor of the right hand, an effect of group but no group\*side interaction. *Post hoc* Sidak tests indicated CR was impaired in patients compared to controls. Relatives did not differ from controls. Likewise, in FT, we detected an effect of side in favor of the right hand, an effect of group but no group\*side interaction. *Post hoc* Sidak tests indicated that patients and relatives performed inferior to controls.

###### 

Performance of fine motor function in patients, relatives and controls.

                   Controls (C); *N* 29   Relatives (R); *N* 34   Patients (P); *N* 43
  ---------------- ---------------------- ----------------------- ----------------------
  CR right (±SE)   14.61 ± 2.97           14.47 ± 2.87            11.96 ± 3.67
  CR left (±SE)    12.82 ± 3.09           12.49 ± 2.87            10.31 ± 4.05
  FT right (±SE)   39.95 ± 8.40           33.77 ± 7.55            35.07 ± 9.49
  FT left (±SE)    37.44 ± 9.15           32.10 ± 6.75            32.82 ± 9.29

*CR, coin rotation; FT, finger tapping*.

![Performance of fine motor function in patients, relatives, and controls. Coin rotation: effect of group *p* = 0.001, effect of side *p* \< 0.001, no effect side × group: *p* = 0.822; *post hoc*: patients \< controls: *p* = 0.003; and relatives \< controls *p* = 0.005. Finger tapping: effect of group: *p* = 0.018, effect of side: *p* \< 0.001, no effect side × group: *p* = 0.646; post hoc: patients \< controls: *p* = 0.061 and relatives \< controls *p* = 0.022.](fpsyt-09-00129-g002){#F2}

Association of Motor Function With Frontal Lobe Function and Working Memory {#S3-2}
---------------------------------------------------------------------------

The association of motor domains including fine motor function with frontal lobe function and working memory is given in Table [5](#T5){ref-type="table"}. Table [4](#T4){ref-type="table"} shows that ratings of some motor domains correlated with performance in motor tests. In fact, fine motor tests (CR and FT) are significantly associated with Parkinsonism in patients and unaffected relatives. Likewise, CR is significantly associated with NSS in patients. In contrast, dyskinesia (AIMS) seems to be independent of fine motor function (CR and FT). In addition, CR is unrelated to frontal lobe function in all groups and to working memory in relatives and controls. Furthermore, frontal lobe function is associated with NSS and Parkinsonism in all groups. Likewise, WM was significantly correlated with motor function in patients. This association is not seen in any other group.

###### 

Association of motor function with frontal lobe function and working memory function in patients, relatives and controls.

                  AIMS                                        UPDRS III                                   CR                                           FT               FAB                                          WM
  --------------- ------------------------------------------- ------------------------------------------- -------------------------------------------- ---------------- -------------------------------------------- --------------------------------------------
  **Patients**                                                                                                                                                                                                       
  NES             **0.357[\*](#tfn1){ref-type="table-fn"}**   **0.760\*\***                               **-0.541\*\***                               −0.300           −**0.628\*\***                               **−0.479\*\***
  AIMS                                                        **0.303[\*](#tfn1){ref-type="table-fn"}**   −0.266                                       −0.046           −0.122                                       −0.101
  UPDRS III                                                                                               −**0.479\*\***                               −**0.412\*\***   −**0.522\*\***                               −0.264
  CR                                                                                                                                                                    0.195                                        **0.349[\*](#tfn1){ref-type="table-fn"}**
  FT                                                                                                                                                                    0.077                                        0.116
  FAB                                                                                                                                                                                                                **0.492\*\***
  WM                                                                                                                                                                                                                 
  **Relatives**                                                                                                                                                                                                      
  NES             0.283                                       **0.356[\*](#tfn1){ref-type="table-fn"}**   −**0.403[\*](#tfn1){ref-type="table-fn"}**   −**0.438\*\***   −**0.399[\*](#tfn1){ref-type="table-fn"}**   −0.299
  AIMS                                                        −0.060                                      −0.318                                       0.073            0.031                                        −**0.378[\*](#tfn1){ref-type="table-fn"}**
  UPDRS III                                                                                               −**0.341[\*](#tfn1){ref-type="table-fn"}**   −**0.496\*\***   −**0.419[\*](#tfn1){ref-type="table-fn"}**   −0.230
  CR                                                                                                                                                                    0.144                                        0.072
  FT                                                                                                                                                                    **0.464\*\***                                0.017
  FAB                                                                                                                                                                                                                0.307
  WM                                                                                                                                                                                                                 
  **Controls**                                                                                                                                                                                                       
  NES             **0.471\*\***                               **0.488\*\***                               −0.337                                       −0.271           −**0.613\*\***                               −0.197
  AIMS                                                        **0.694\*\***                               −0.041                                       −0.169           −**0.623\*\***                               −0.121
  UPDRS III                                                                                               −0.104                                       −0.007           −**0.432[\*](#tfn1){ref-type="table-fn"}**   −0.084
  CR                                                                                                                                                                    0.335                                        −0.155
  FT                                                                                                                                                                    0.312                                        −0.027
  FAB                                                                                                                                                                                                                0.127
  WM                                                                                                                                                                                                                 

*NES, Neurological Evaluation Scale; AIMS, Abnormal Involuntary Movement Scale; UPDRS III, Unified Parkinson's Disease Rating Scale motor part III; CR, coin rotation; FT, finger tapping; FAB, frontal assessment battery; DSB, digit span backwards*.

*\*p \< 0.05; \*\*p \< 0.01*.

*Note: significant associations are highlighted in bold*.

Discussion {#S4}
==========

Increasing evidence has established the clinical relevance of aberrant motor function in schizophrenia ([@B1], [@B47]--[@B49]). Here, we investigated a comprehensive motor battery with four domains of motor function in three well-characterized groups (patients, unaffected first-degree relatives and healthy controls). The study aimed to explore, which motor domains were particularly associated with the genetic risk for psychosis. We were able to confirm our main hypotheses, and demonstrated (1) generalized aberrant motor function in schizophrenia patients, and (2) aberrant motor function in some but not all motor domains in schizophrenia relatives. The distinct pattern of associations between genetic psychosis risk and motor domains argues for different pathophysiological mechanisms behind each motor domain.

As hypothesized, aberrant motor function was shown for NSS in schizophrenia relatives compared to controls with intermediate severity. Moreover, NSS are thought to indicate aberrant motor development that is even evident in adults. Aberrant motor development has been associated with a genetic psychosis risk ([@B9]). Thus, NSS have been discussed as endophenotype markers in psychosis ([@B50]). In contrast, we were not able to confirm our hypothesis of an association between genetic psychosis risk and defective coin rotation, which is a reliable and simple measure of complex fine motor function. In fact, in unaffected first-degree relatives fine motor function was preserved. However, in schizophrenia we detected aberrant complex fine motor function with the coin rotation task. In addition, patients and relatives performed worse than healthy controls in the simple fine motor task. Finally, relatives had similar severity of Parkinsonism and dyskinesia compared to healthy controls, which is different from the findings regarding NSS. Thus, our results confirm the specific importance of NSS for the genetic psychosis risk. Therefore, NSS may in the future be particularly useful to monitor vulnerable subjects.

Generalized Aberrant Motor Function in Schizophrenia {#S4-1}
----------------------------------------------------

Patients had an increased severity of NSS, dyskinesia and Parkinsonism. In addition, we detected aberrant fine motor function (FT and CR) in patients. Thus, in line with the literature we found generalized aberrant motor function in schizophrenia patients and extended the knowledge by demonstrating further alterations in complex fine motor function, which has been understudied. Complex fine motor function (i.e., manual dexterity as measured with the CR task) adopts an intermediate position between higher-order (i.e., apraxic) and elemental motor function. Aberrant complex fine motor function is characterized by impaired control of selective and coordinated hand and finger movements, not explained by weakness or sensory deficits ([@B51]). Aberrant function in this domain may impact performance of skilled movements in schizophrenia, such as hand gestures ([@B14], [@B52]--[@B55]). Similar deficits have previously been shown in Parkinson's disease ([@B35]). Taken together, exploring the pathophysiology underlying complex fine motor function, incorporating instrumental approaches, may add to the innovative research in the field of motor function in schizophrenia.

Aberrant Motor Function in Specific Motor Domains in Unaffected First-Degree Relatives {#S4-2}
--------------------------------------------------------------------------------------

Unaffected first-degree relatives of schizophrenia patients showed aberrant motor function in some but not all investigated motor domains. In line with the literature, we found more NSS in relatives compared to healthy controls. Nearly all studies ([@B56]--[@B60]) and recent meta-analyses ([@B8], [@B21]) confirmed an increased severity of NSS in relatives of schizophrenia patients. Thus, NSS are very likely to be associated with the genetic risk for psychosis. However, some reports were negative, probably owing to inclusion of a considerable proportion of second-degree relatives ([@B61]) or the lack of specific NSS rating scales ([@B62]). Besides the total NSS severity, we detected differences between relatives and controls in two of the NES subscales, i.e., "sequencing of motor acts" (i.e., fist-ring test, the fist-edge-palm test, the Ozeretski test) and "others" (i.e., adventitious overflow, Romberg test, tremor, memory, mirror movements). Interestingly, a previous study reported increased heritability in the same subscales, with a correlation between NSS severity of patients and NSS severity of their siblings ([@B56]).

In contrast, relatives had no increased severity of dyskinesia and Parkinsonism in our sample. In line with this, some previous reports failed to detect increased dyskinesia in relatives ([@B24], [@B25]). Likewise, one study reported a relatively low incidence of parkinsonism (incidence 3% of the sample in 181 subjects) in unaffected relatives of schizophrenia patients ([@B27]). Yet, no control group was included in this latter study. In contrast, other reports ([@B63]) demonstrate an increased severity of dyskinesia ([@B63]) and Parkinsonism ([@B26], [@B63]) in schizophrenia relatives compared to healthy controls. Thus, whether dyskinesia or Parkinsonism is truly associated with the genetic risk for psychosis requires further clarification in larger samples. Alternatively, dyskinesia and Parkinsonism may exclusively occur in subjects at increased risk for psychosis, who have prodromal signs beyond a genetic risk ([@B23], [@B64], [@B65]).

Finally, while patients showed impaired complex fine motor function, in relatives, complex fine motor function (CR) was intact. No previous report investigated complex fine motor function (CR) in unaffected first-degree relatives. Currently, our findings argue for an association of impaired complex fine motor function with psychosis but not with genetic psychosis risk. In contrast to complex fine motor function and in line with one previous report, simple fine motor function was impaired in both patients and relatives and may, therefore, be associated with psychosis and the genetic risk ([@B36]).

To conclude, we demonstrated increased incidence of NSS and impaired simple fine motor function in schizophrenia relatives arguing for a particular relevance as a genetic risk marker. In contrast, dyskinesia, Parkinsonism and complex fine motor function were not impaired and are, therefore, unlikely to become relevant indicators of the genetic risk for psychosis.

Aberrant Motor Function of Different Domains Linked to Distinct Alterations in the Motor System {#S4-3}
-----------------------------------------------------------------------------------------------

In general, motor abnormalities in schizophrenia have been consistently associated with alterations in the cerebral motor system ([@B48], [@B66]--[@B68]). In addition, psychosis was associated with altered functional and structural connectivity in the motor system ([@B68]--[@B77]). Likewise, during motor tasks functional alterations in the motor system were detected in schizophrenia ([@B78]). Importantly, while there is some overlap, aberrant motor behavior of distinct motor domains is associated with specific structural and functional alterations ([@B72], [@B79]), i.e., not one mechanism associated with all domains of aberrant motor behavior in psychosis.

A large body of evidence associates NSS in schizophrenia with structural and functional alterations within cortical premotor and motor areas, the cerebellum and thalamus ([@B48]). In detail, NSS are linked to gray matter (GM) abnormalities in cortical areas comprising the pre- and postcentral gyri, premotor areas, inferior and middle frontal gyri ([@B80], [@B81]). Likewise, studies using cortical thickness or sulcation found NSS to be associated with aberrant morphology of frontal, temporal, and parietal areas ([@B82], [@B83]). Subcortical structures related to NSS in schizophrenia included the thalamus, caudate nucleus, putamen, globus pallidus ([@B84], [@B85]) as well as the cerebellum ([@B80], [@B86], [@B87]). Importantly, even medication-naive first-episode patients show an association of aberrant motor sequencing and GM alterations of cortical and subcortical structures ([@B88]). Interestingly, a longitudinal study further confirmed that persisting compared to decreasing NSS in first-episode schizophrenia is related to a progressive decrease of GM volume ([@B89]). White matter density has shown to be related to NSS in the inferior frontal gyrus, cerebellum, and corpus callosum in schizophrenia ([@B80], [@B81]). Furthermore, abnormal white matter cerebellar--thalamic tract development predicted NSS after 12 months in ultra-high risk individuals ([@B90]). Besides these structural abnormalities, some studies explored functional neural underpinnings of NSS ([@B91]). In a paradigm that compared the fist-edge-palm task with a simple motor task, patients with schizophrenia failed to activate the left middle frontal gyrus which was the case in healthy controls ([@B92]). In addition, with increasing task difficulty, functional connectivity changed between the sensorimotor cortex and the right frontal gyrus in patients compared to healthy controls ([@B92]). Thus, altered brain morphology and function may account for NSS in patients.

Brain imaging studies in schizophrenia and Parkinson's disease reported associations of dyskinesia and Parkinsonism with basal ganglia dysfunction. For instance, patients with dyskinesia had reduced GM volume in the caudate nucleus, putamen, globus pallidus, and the thalamus ([@B93]). Likewise, altered volume of the striatum was shown in medication naïve chronic schizophrenia patients with dyskinesia ([@B94]) and volume alterations in the putamen were evident in subjects at risk with dyskinesia ([@B95]). Furthermore, white matter alterations within cortico-basal ganglia circuits correlated with involuntary movements in schizophrenia ([@B96]). Accordingly, early functional imaging studies reported that activity in the basal ganglia (higher relative metabolic rates in the putamen) was associated with dyskinesia severity in schizophrenia ([@B97]). In addition, D2/D3 receptor availability in the striatum was linked to Parkinsonism in schizophrenia ([@B98]). In addition, there is some conceptual overlap between Parkinsonism and reduced spontaneous motor activity, which is also paralleled by alterations of the cerebral motor system ([@B72], [@B76], [@B77]). The relatives in the current study had no increased severity of Parkinsonism. We may speculate that alterations in the suspected underlying brain areas are lacking in relatives. In contrast, basal ganglia shape abnormalities were also reported in unaffected siblings of schizophrenia patients ([@B99]). However, a recent study detected no alterations of caudate and putamen laterality indices in schizophrenia siblings, who did not significantly differ from controls ([@B100]) and abnormal striatal and ventricle volumes showed no sign of heritability ([@B101]). Thus, whether alterations in the basal ganglia are critical for dyskinesia and Parkinsonism in relatives of schizophrenia patients remains to be explored.

Finally, patients had significantly impaired complex fine motor function. Until now, no study investigated neural correlates of impaired coin rotation (complex fine motor function) in schizophrenia. In general, for complex fine motor function, temporal, and spatial information of the movement has to be retrieved and translated into motor output. According to modern models ([@B102]) brain areas of the so-called praxis network ([@B103]) are involved. Inferior parietal lobule (IPL) and intact connections between IPL and left premotor cortex and supplementary motor area are expected to critically contribute to complex fine motor function ([@B51], [@B104]--[@B107]). In line with these proposed models we recently detected differentially altered activation and altered functional coupling in key areas of the left praxis network to be linked to altered complex fine motor function (CR) in Parkinson's disease ([@B35]). Likewise we detected associations of functional and structural alterations in the praxis network with gesture performance in schizophrenia patients ([@B108]--[@B110]). However, future studies are needed to address the neural correlates of impaired complex fine motor function in schizophrenia.

Association of Motor Function With Frontal Lobe Function and Working Memory {#S4-4}
---------------------------------------------------------------------------

Critical contributors to aberrant motor skills in schizophrenia are working memory and frontal lobe functioning. We, therefore, tested, whether frontal lobe function and working memory correlated with the motor domains in each group. In fact, in our study some motor domains (NSS and Parkinsonism) were associated with frontal lobe function across groups. However, there is also considerable conceptual overlap between motor skills and frontal lobe function. For instance the FAB and the NES share some items such as the fist-edge-palm test.

The pattern of correlations was different for working memory. Only in patients working memory was correlated with motor domains. This may be due to the fact that in our study working memory performance was relatively intact in relatives and healthy controls. Thus, given that motor abilities rely on frontal lobe and working memory function, working memory deficits may have impaired motor function in patients, while altered frontal lobe function compromised motor skills in all three groups. In contrast, working memory deficits were unlikely to account for motor abnormalities in relatives.

Limitations {#S4-5}
-----------

Some limitations of this study require discussion. The sample was predominantly female as women more frequently agreed to participation. As groups were matched for age, gender and education, the proportion of women was equal across groups. Still, former studies showed no gender effect on NSS severity in patients ([@B111]). In addition, most of our patients were medicated. Antipsychotic medication may impact motor behavior. For instance dyskinesia and Parkinsonism were typically attributed to medication (i.e., tardive dyskinesia), even though evidence suggests that these motor abnormalities may also occur spontaneously in drug naïve patients ([@B1], [@B5], [@B10], [@B112]--[@B114]). We used the NES to assess NSS, but whether our results are comparable to other instruments remains unclear due to inconsistent terminology across instruments ([@B59], [@B115]) \[e.g., overlap of motor coordination ([@B116]) and sequencing of motor acts in the NES\]. Finally, although we assessed a comprehensive battery of various motor domains, other important domains have not been studied. For example, we did not test postural sway ([@B117]), which is an interesting measure of cerebellar function.

Conclusion {#S4-6}
----------

Modern theories for the development of psychosis suggest that environmental stressors, such as early childhood adversities, together with neurodevelopmental abnormalities may lead to psychosis. One particular marker of neurodevelopmental abnormalities is aberrant motor function. We were able to confirm generalized aberrant motor function in schizophrenia patients and aberrant motor function in some but not all tested motor domains in first-degree relatives of schizophrenia patients. The pattern of alterations in relatives suggests distinct mechanisms in each of the motor domains typically affected in psychosis. Particularly, relatives had increased NSS severity, which may reflect abnormal motor skill development. Thus, NSS could become a specific marker of the genetic risk for psychosis. Importantly such objective markers may not only inform on the etiology of psychosis but may be relevant for screening and staging of psychosis. Finally, markers of aberrant motor function may guide individualized treatment regimen in the future. Yet, future studies with sensitive technical instruments to measure and quantify different motor abnormalities are warranted to confirm our results in longitudinal studies.
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